1. Home
  2. SPRY vs SBSI Comparison

SPRY vs SBSI Comparison

Compare SPRY & SBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • SBSI
  • Stock Information
  • Founded
  • SPRY 2015
  • SBSI 1960
  • Country
  • SPRY United States
  • SBSI United States
  • Employees
  • SPRY N/A
  • SBSI N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • SBSI Major Banks
  • Sector
  • SPRY Health Care
  • SBSI Finance
  • Exchange
  • SPRY Nasdaq
  • SBSI Nasdaq
  • Market Cap
  • SPRY 1.1B
  • SBSI 920.2M
  • IPO Year
  • SPRY N/A
  • SBSI N/A
  • Fundamental
  • Price
  • SPRY $9.59
  • SBSI $29.84
  • Analyst Decision
  • SPRY Strong Buy
  • SBSI Hold
  • Analyst Count
  • SPRY 4
  • SBSI 3
  • Target Price
  • SPRY $31.25
  • SBSI $33.50
  • AVG Volume (30 Days)
  • SPRY 2.5M
  • SBSI 166.4K
  • Earning Date
  • SPRY 11-10-2025
  • SBSI 10-24-2025
  • Dividend Yield
  • SPRY N/A
  • SBSI 4.90%
  • EPS Growth
  • SPRY N/A
  • SBSI N/A
  • EPS
  • SPRY N/A
  • SBSI 2.30
  • Revenue
  • SPRY $142,772,000.00
  • SBSI $236,346,000.00
  • Revenue This Year
  • SPRY N/A
  • SBSI $11.21
  • Revenue Next Year
  • SPRY $193.13
  • SBSI $5.52
  • P/E Ratio
  • SPRY N/A
  • SBSI $12.78
  • Revenue Growth
  • SPRY 5459.66
  • SBSI N/A
  • 52 Week Low
  • SPRY $6.66
  • SBSI $25.85
  • 52 Week High
  • SPRY $18.90
  • SBSI $36.04
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 57.78
  • SBSI 63.07
  • Support Level
  • SPRY $6.66
  • SBSI $28.23
  • Resistance Level
  • SPRY $7.40
  • SBSI $29.95
  • Average True Range (ATR)
  • SPRY 0.80
  • SBSI 0.60
  • MACD
  • SPRY 0.21
  • SBSI 0.14
  • Stochastic Oscillator
  • SPRY 78.83
  • SBSI 94.24

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About SBSI Southside Bancshares Inc.

Southside Bancshares Inc is a bank holding company. Through its subsidiary, the Southside Bank, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.

Share on Social Networks: